The impact of glucocorticoids and anti-cd20 therapy on cervical human papillomavirus infection risk in women with systemic lupus erythematosus. [electronic resource]
Producer: 20140930Description: 1475-80 p. digitalISSN:- 1980-5322
- Adult
- Antibodies, Monoclonal, Murine-Derived -- adverse effects
- Cervix Uteri -- cytology
- Cross-Sectional Studies
- DNA, Viral
- Female
- Genotype
- Glucocorticoids -- adverse effects
- Humans
- Immunologic Factors -- adverse effects
- Logistic Models
- Lupus Erythematosus, Systemic -- complications
- Mexico -- epidemiology
- Middle Aged
- Papillomavirus Infections -- chemically induced
- Polymerase Chain Reaction
- Prevalence
- Risk Factors
- Rituximab
- Socioeconomic Factors
- Uterine Cervical Diseases -- chemically induced
- Vaginal Smears
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.